Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Tourette Syndrome Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Tourette Syndrome Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Tourette Syndrome Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Tourette Syndrome Drug Market Size Growth Rate by Type
    • 1.4.2 AZD-5213
    • 1.4.3 CPP-115
    • 1.4.4 Dutetrabenazine ER
    • 1.4.5 Ecopipam Hydrochloride
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Tourette Syndrome Drug Market Size Growth Rate by Application
    • 1.5.2 Research Center
    • 1.5.3 Hospital
    • 1.5.4 Clinic
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Tourette Syndrome Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global Tourette Syndrome Drug Revenue 2015-2026
    • 2.1.2 Global Tourette Syndrome Drug Sales 2015-2026
  • 2.2 Global Tourette Syndrome Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Tourette Syndrome Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Tourette Syndrome Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Tourette Syndrome Drug Competitor Landscape by Players

  • 3.1 Tourette Syndrome Drug Sales by Manufacturers
    • 3.1.1 Tourette Syndrome Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Tourette Syndrome Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Tourette Syndrome Drug Revenue by Manufacturers
    • 3.2.1 Tourette Syndrome Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Tourette Syndrome Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Tourette Syndrome Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Tourette Syndrome Drug Revenue in 2019
    • 3.2.5 Global Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Tourette Syndrome Drug Price by Manufacturers
  • 3.4 Tourette Syndrome Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Tourette Syndrome Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Tourette Syndrome Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Tourette Syndrome Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Tourette Syndrome Drug Market Size by Type (2015-2020)
    • 4.1.1 Global Tourette Syndrome Drug Sales by Type (2015-2020)
    • 4.1.2 Global Tourette Syndrome Drug Revenue by Type (2015-2020)
    • 4.1.3 Tourette Syndrome Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Tourette Syndrome Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Tourette Syndrome Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Tourette Syndrome Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 Tourette Syndrome Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Tourette Syndrome Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Tourette Syndrome Drug Market Size by Application (2015-2020)
    • 5.1.1 Global Tourette Syndrome Drug Sales by Application (2015-2020)
    • 5.1.2 Global Tourette Syndrome Drug Revenue by Application (2015-2020)
    • 5.1.3 Tourette Syndrome Drug Price by Application (2015-2020)
  • 5.2 Tourette Syndrome Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Tourette Syndrome Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Tourette Syndrome Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Tourette Syndrome Drug Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Tourette Syndrome Drug by Country
    • 6.1.1 North America Tourette Syndrome Drug Sales by Country
    • 6.1.2 North America Tourette Syndrome Drug Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Tourette Syndrome Drug Market Facts & Figures by Type
  • 6.3 North America Tourette Syndrome Drug Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Tourette Syndrome Drug by Country
    • 7.1.1 Europe Tourette Syndrome Drug Sales by Country
    • 7.1.2 Europe Tourette Syndrome Drug Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Tourette Syndrome Drug Market Facts & Figures by Type
  • 7.3 Europe Tourette Syndrome Drug Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Tourette Syndrome Drug by Region
    • 8.1.1 Asia Pacific Tourette Syndrome Drug Sales by Region
    • 8.1.2 Asia Pacific Tourette Syndrome Drug Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Tourette Syndrome Drug Market Facts & Figures by Type
  • 8.3 Asia Pacific Tourette Syndrome Drug Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Tourette Syndrome Drug by Country
    • 9.1.1 Latin America Tourette Syndrome Drug Sales by Country
    • 9.1.2 Latin America Tourette Syndrome Drug Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Tourette Syndrome Drug Market Facts & Figures by Type
  • 9.3 Central & South America Tourette Syndrome Drug Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Tourette Syndrome Drug by Country
    • 10.1.1 Middle East and Africa Tourette Syndrome Drug Sales by Country
    • 10.1.2 Middle East and Africa Tourette Syndrome Drug Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Tourette Syndrome Drug Market Facts & Figures by Type
  • 10.3 Middle East and Africa Tourette Syndrome Drug Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Abide Therapeutics Inc
    • 11.1.1 Abide Therapeutics Inc Corporation Information
    • 11.1.2 Abide Therapeutics Inc Description and Business Overview
    • 11.1.3 Abide Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Products Offered
    • 11.1.5 Abide Therapeutics Inc Related Developments
  • 11.2 Catalyst Pharmaceuticals Inc
    • 11.2.1 Catalyst Pharmaceuticals Inc Corporation Information
    • 11.2.2 Catalyst Pharmaceuticals Inc Description and Business Overview
    • 11.2.3 Catalyst Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
    • 11.2.5 Catalyst Pharmaceuticals Inc Related Developments
  • 11.3 Neurocrine Biosciences Inc
    • 11.3.1 Neurocrine Biosciences Inc Corporation Information
    • 11.3.2 Neurocrine Biosciences Inc Description and Business Overview
    • 11.3.3 Neurocrine Biosciences Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Products Offered
    • 11.3.5 Neurocrine Biosciences Inc Related Developments
  • 11.4 Psyadon Pharmaceuticals Inc
    • 11.4.1 Psyadon Pharmaceuticals Inc Corporation Information
    • 11.4.2 Psyadon Pharmaceuticals Inc Description and Business Overview
    • 11.4.3 Psyadon Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
    • 11.4.5 Psyadon Pharmaceuticals Inc Related Developments
  • 11.5 Reviva Pharmaceuticals Inc
    • 11.5.1 Reviva Pharmaceuticals Inc Corporation Information
    • 11.5.2 Reviva Pharmaceuticals Inc Description and Business Overview
    • 11.5.3 Reviva Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
    • 11.5.5 Reviva Pharmaceuticals Inc Related Developments
  • 11.6 Synchroneuron Inc
    • 11.6.1 Synchroneuron Inc Corporation Information
    • 11.6.2 Synchroneuron Inc Description and Business Overview
    • 11.6.3 Synchroneuron Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Synchroneuron Inc Tourette Syndrome Drug Products Offered
    • 11.6.5 Synchroneuron Inc Related Developments
  • 11.7 Teva Pharmaceutical Industries Ltd
    • 11.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
    • 11.7.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
    • 11.7.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Products Offered
    • 11.7.5 Teva Pharmaceutical Industries Ltd Related Developments
  • 11.8 Therapix Biosciences Ltd
    • 11.8.1 Therapix Biosciences Ltd Corporation Information
    • 11.8.2 Therapix Biosciences Ltd Description and Business Overview
    • 11.8.3 Therapix Biosciences Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Products Offered
    • 11.8.5 Therapix Biosciences Ltd Related Developments
  • 11.1 Abide Therapeutics Inc
    • 11.1.1 Abide Therapeutics Inc Corporation Information
    • 11.1.2 Abide Therapeutics Inc Description and Business Overview
    • 11.1.3 Abide Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Products Offered
    • 11.1.5 Abide Therapeutics Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Tourette Syndrome Drug Market Estimates and Projections by Region
    • 12.1.1 Global Tourette Syndrome Drug Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Tourette Syndrome Drug Revenue Forecast by Regions 2021-2026
  • 12.2 North America Tourette Syndrome Drug Market Size Forecast (2021-2026)
    • 12.2.1 North America: Tourette Syndrome Drug Sales Forecast (2021-2026)
    • 12.2.2 North America: Tourette Syndrome Drug Revenue Forecast (2021-2026)
    • 12.2.3 North America: Tourette Syndrome Drug Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Tourette Syndrome Drug Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Tourette Syndrome Drug Sales Forecast (2021-2026)
    • 12.3.2 Europe: Tourette Syndrome Drug Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Tourette Syndrome Drug Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Tourette Syndrome Drug Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Tourette Syndrome Drug Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Tourette Syndrome Drug Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Tourette Syndrome Drug Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Tourette Syndrome Drug Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Tourette Syndrome Drug Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Tourette Syndrome Drug Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Tourette Syndrome Drug Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Tourette Syndrome Drug Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Tourette Syndrome Drug Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Tourette Syndrome Drug Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Tourette Syndrome Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Tourette Syndrome Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Tourette Syndrome Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Tourette Syndrome Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tourette Syndrome Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Tourette Syndrome Drug market is segmented into
    AZD-5213
    CPP-115
    Dutetrabenazine ER
    Ecopipam Hydrochloride
    Others

    Segment by Application, the Tourette Syndrome Drug market is segmented into
    Research Center
    Hospital
    Clinic
    Others

    Regional and Country-level Analysis
    The Tourette Syndrome Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Tourette Syndrome Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Tourette Syndrome Drug Market Share Analysis
    Tourette Syndrome Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tourette Syndrome Drug business, the date to enter into the Tourette Syndrome Drug market, Tourette Syndrome Drug product introduction, recent developments, etc.

    The major vendors covered:
    Abide Therapeutics Inc
    Catalyst Pharmaceuticals Inc
    Neurocrine Biosciences Inc
    Psyadon Pharmaceuticals Inc
    Reviva Pharmaceuticals Inc
    Synchroneuron Inc
    Teva Pharmaceutical Industries Ltd
    Therapix Biosciences Ltd

    Buy now